Nontoss (Butamirate Citrate)

Butamirate Citrate, the active ingredient in Nontoss, is a cough suppressant presented as an oral dosage form for oral use. It treats dry (non‑productive) cough in adults and children. GNH USA supplies Nontoss as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Butamirate Citrate is an antitussive that acts on the cough centre to reduce irritation‑driven coughing. - Dry (non‑productive) cough: decreases cough frequency and intensity. - Cough associated with common cold: provides symptomatic relief without affecting mucus clearance. - Throat irritation‑related cough: suppresses the cough reflex caused by mild airway irritation.

Butamirate citrate is generally well tolerated, but some patients may experience adverse reactions.

Common Side Effects: - Drowsiness: mild sleepiness reported in some users. - Nausea: occasional upset stomach. - Dry mouth: reduced salivation. - Dizziness: transient light‑headedness. - Headache: mild to moderate. - Gastrointestinal discomfort: mild abdominal pain or bloating.

Serious or Rare Side Effects: - Allergic reactions: rash, itching, or angioedema. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: abnormal liver enzymes. - Neutropenia: reduced white blood cell count. - Anaphylaxis: rapid onset of systemic allergic response.

When using butamirate citrate, consider the following safety measures. - Use in children: follow prescriber guidance and age‑appropriate dosing. - Known hypersensitivity: avoid if allergic to butamirate or excipients. - Concomitant CNS depressants: use with caution as additive sedation may occur. - Hepatic impairment: monitor liver function and adjust use if needed. - Duration of therapy: do not exceed the prescribed treatment period without medical advice. - Store at room temperature: keep in the original pack, protect from moisture.

Butamirate citrate may interact with other substances that affect the central nervous system or metabolism.

Major Interactions (Avoid): - Alcohol: can enhance sedative effects and increase drowsiness. - Opioid analgesics: additive CNS depression may occur. - Benzodiazepines: risk of excessive sedation.

Moderate Interactions (Monitor Closely): - Antihistamines: may increase anticholinergic side effects such as dry mouth. - Anticholinergic agents: monitor for enhanced dryness and constipation.